Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
129-143
Author(s):
Carl Turesson
Endothelial Chemokines in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
145-154
Author(s):
Kent W. Christopherson II and Robert A. Hromas
Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
155-161
Author(s):
Mae-Xhum Wong and Denise E. Jackson
Dendritic Cell Endothelium Interaction in Autoimmunity
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
171-181
Author(s):
C. L. Schlichting, W. D. Schareck and M. Weis
Erythropoietin Withdrawal Leads to the Destruction of Young Red Cells at the Endothelial-Macrophage Interface
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
183-190
Author(s):
J. Trial and L. Rice
Red Blood Cells as Modulators of T Cell Growth and Survival
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
191-201
Author(s):
Fernando A. Arosa, Carlos F. Pereira and Ana M. Fonseca
Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
203-211
Author(s):
Juan Acosta, Xuebin Qin and Jose Halperin
Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
213-221
Author(s):
Y. S. Lin, C. F. Lin, H. Y. Lei, H. S. Liu, T. M. Yeh, S. H. Chen and C. C. Liu
Cationic Lipid-DNA Complexes for Gene Therapy: Understanding the Relationship Between Complex Structure and Gene Delivery Pathways at the Molecular Level
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
133-149
Author(s):
Kai Ewert, Nelle L. Slack, Ayesha Ahmad, Heather M. Evans, Alison J. Lin, Charles E. Samuel and Cyrus R. Safinya
α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
241-252
Author(s):
Yoshihiro Hayakawa, Dale I. Godfrey and Mark J. Smyth